Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease

International Journal of Cardiology

Volumn 230, Issue , 2017, Pages 33-39

  Wang, Cheng ^a   Zhang, Jun ^a   Li, Yan ^b   Ma, Xinxin ^a   Ye, Zengchun ^a   Peng, Hui ^a   Lou, Tanqi ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ambulatory blood pressure (BP); Chronic kidney disease (CKD); Clinic blood pressure; Masked hypertension; White coat hypertension

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MORTALITY RISK; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SUSTAINED HYPERTENSION; WHITE COAT HYPERTENSION; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASKED HYPERTENSION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; WHITE COAT HYPERTENSION; YOUNG ADULT;

EID: 85009260560     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.12.105     Document Type: Article

References (30)

1. [1] Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment, Lancet Diabetes Endocrinol 2 (2014) 634–647.
2. [2] Johnson, E.S., Thorp, M.L., Yang, X., Charansonney, O.L., Smith, D.H., Predicting renal replacement therapy and mortality in CKD. Am. J. Kidney Dis. 50 (2007), 559–565.
3. [3] Tonelli, M., Wiebe, N., Culleton, B., House, A., Rabbat, C., Fok, M., et al. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17 (2006), 2034–2047.
4. [4] Clement, D.L., De Buyzere, M.L., De Bacquer, D.A., de Leeuw, P.W., Duprez, D.A., Fagard, R.H., et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348 (2003), 2407–2415.
5. [5] Vinyoles, E., Felip, A., Pujol, E., de la Sierra, A., Dura, R., Del, R.R., et al. Clinical characteristics of isolated clinic hypertension. J. Hypertens. 26 (2008), 438–445.
6. [6] Bangash, F., Agarwal, R., Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin. J. Am. Soc. Nephrol. 4 (2009), 656–664.
7. [7] Cacciolati, C., Hanon, O., Dufouil, C., Alperovitch, A., Tzourio, C., Categories of hypertension in the elderly and their 1-year evolution. The Three-City Study. J. Hypertens. 31 (2013), 680–689.
8. [8] Pierdomenico, S.D., Cuccurullo, F., Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am. J. Hypertens. 24 (2011), 52–58.
9. [9] Minutolo, R., Borrelli, S., Scigliano, R., Bellizzi, V., Chiodini, P., Cianciaruso, B., et al. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Nephrol. Dial. Transplant. 22 (2007), 2217–2223.
10. [10] Pogue, V., Rahman, M., Lipkowitz, M., Toto, R., Miller, E., Faulkner, M., et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53 (2009), 20–27.
11. [11] Tang, H., Gong, W.Y., Zhang, Q.Z., Zhang, J., Ye, Z.C., Peng, H., et al. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease. Nephrology (Carlton) 21 (2016), 841–850.
12. [12] Andrassy, K.M., Comments on ‘KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease’. Kidney Int. 84 (2013), 622–623.
13. [13] Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.R., Feldman, H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (2009), 604–612.
14. [14] (2) Classification and diagnosis of diabetes, Diabetes. Care. 38 Suppl (2015) S8-S16.
15. [15] Gabbai, F.B., Rahman, M., Hu, B., Appel, L.J., Charleston, J., Contreras, G., et al. Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin. J. Am. Soc. Nephrol. 7 (2012), 1770–1776.
16. [16] Alpert, J.S., Thygesen, K., Antman, E., Bassand, J.P., Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36 (2000), 959–969.
17. [17] Luepker, R.V., Apple, F.S., Christenson, R.H., Crow, R.S., Fortmann, S.P., Goff, D., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003), 2543–2549.
18. [18] Medical Biostatistics & Research. http://www.medicalbiostatistics.com/.
19. [19] Pocock, S.J., Clayton, T.C., Altman, D.G., Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 359 (2002), 1686–1689.
20. [20] Stergiou, G.S., Asayama, K., Thijs, L., Kollias, A., Niiranen, T.J., Hozawa, A., et al. Prognosis of white-coat and masked hypertension: International Database of Home blood pressure in relation to Cardiovascular Outcome. Hypertension 63 (2014), 675–682.
21. [21] Kanno, A., Metoki, H., Kikuya, M., Terawaki, H., Hara, A., Hashimoto, T., et al. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Hypertens. Res. 33 (2010), 1192–1198.
22. [22] Ohkubo, T., Kikuya, M., Metoki, H., Asayama, K., Obara, T., Hashimoto, J., et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J. Am. Coll. Cardiol. 46 (2005), 508–515.
23. [23] Liu, L., Using multivariate quantile regression analysis to explore cardiovascular risk differences in subjects with chronic kidney disease by race and ethnicity: findings from the US Chronic Renal Insufficiency Cohort Study. Int. Cardiovasc. Forum J., 2015, 20–26.
24. [24] Andalib, A., Akhtari, S., Rigal, R., Curnew, G., Leclerc, J.M., Vaillancourt, M., et al. Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Intern. Med. J. 42 (2012), 260–266.
25. [25] Mancia, G., Bombelli, M., Seravalle, G., Grassi, G., Diagnosis and management of patients with white-coat and masked hypertension. Nat. Rev. Cardiol. 8 (2011), 686–693.
26. [26] Verdecchia, P., Angeli, F., Mazzotta, G., Garofoli, M., Ramundo, E., Gentile, G., et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 60 (2012), 34–42.
27. [27] Cha, R.H., Kim, S., Ae, Y.S., Ryu, D.R., Eun, O.J., Han, S.Y., et al. Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study. Hypertens. Res. 37 (2014), 172–178.
28. [28] Minutolo, R., Gabbai, F.B., Agarwal, R., Chiodini, P., Borrelli, S., Bellizzi, V., et al. Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. Am. J. Kidney Dis. 64 (2014), 744–752.
29. [29] Kushiro, T., Kario, K., Saito, I., Teramukai, S., Sato, Y., Okuda, Y., et al. Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study. Hypertens. Res., 2016.
30. [30] Siven, S.S., Niiranen, T.J., Kantola, I.M., Jula, A.M., White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study. J. Hypertens. 34 (2016), 54–60.